FDA Approved: DEXLANSOPRAZOLE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approval of Mylan's original ANDA for dexlansoprazole, providing a generic version of the proton pump inhibitor to treat acid-related disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• DEXLANSOPRAZOLE (DEXLANSOPRAZOLE)

Snippet

ORIG AP for DEXLANSOPRAZOLE (DEXLANSOPRAZOLE)